"At Duke Neurological Disorders Clinic - Clinic 1L, we are dedicated to providing advanced, compassionate neurology care."

During the past decade, Duke Neurological Disorders Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Neurological Disorders Clinic" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Duke Neurological Disorders Clinic" are "Amyotrophic Lateral Sclerosis" (2 trials), "ALS (Amyotrophic Lateral Sclerosis)" (1 trials), "Amyotrophic Lateral Sclerosis (ALS)" (1 trials), "Migraine Headache" (1 trials) and "Small Fiber Neuropathy" (1 trials). Many other conditions were trialed in "Duke Neurological Disorders Clinic" in a lesser frequency.

Most popular intervention types in "Duke Neurological Disorders Clinic" are "Drug" (5 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Historical control" (1 trials), "Lunasin Regimen" (1 trials), "Placebo tablets" (1 trials) and "Reldesemtiv" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Neurological Disorders Clinic" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Duke Neurological Disorders Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Duke Neurological Disorders Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke Neurological Disorders Clinic, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".